Pregnancy Related Clinical Trial
— eVOLVEOfficial title:
Evaluating the Effectiveness of the Saving Babies Lives Care Bundle Version 2 on Reducing Perinatal Mortality
NCT number | NCT06453954 |
Other study ID # | 325846 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 17, 2023 |
Est. completion date | February 21, 2024 |
Verified date | June 2024 |
Source | University of Manchester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to learn about the implementation of NHS England's Saving Babies Lives Care Bundle Version 2 to reduce perinatal mortality. It will explore whether the care bundle is effective at reducing stillbirth rates, neonatal death rates and preterm births in England. It will also explore the lived experiences of women's maternity care and their babies neonatal care, and the views and experiences of healthcare professionals who are involved in delivering the care bundle. The main questions it aims to answer are: - Does the care bundle reduce perinatal mortality rates? - What are women's views and experiences of their maternity and neonatal care? - What are the barriers around delivering the care bundle and how can this be improved? - How do health inequalities affect the care women receive? - How does the workforce culture affect how healthcare professionals use the care bundle? Perinatal mortality rates and other pregnancy outcomes will be obtained from national data sources. Women and healthcare professionals will be asked to complete a survey and we will interview select groups of participants to further explore their experiences. Mortality rates will be compared before and after the implementationof the care bundle where data allows. Data from the surveys will be descriptive. Data from the interviews will be analysed using thematic analysis to determine patterns and recurring ideas in the data.
Status | Completed |
Enrollment | 1773 |
Est. completion date | February 21, 2024 |
Est. primary completion date | January 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years and older |
Eligibility | Phase 1: All births in England. Phase 2: Inclusion Criteria: - women who have given birth in the last 12 months - women who can understand English - healthcare professionals involved in delivering the care bundle Exclusion Criteria: - women who gave birth more than 12 months ago - women who cannot understand English - women without access to the internet for online survey completion - healthcare professionals not involved in delivering the care bundle |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Manchester Foundation Trust | Manchester |
Lead Sponsor | Collaborator |
---|---|
University of Manchester |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of stillbirths in England | A baby born after 24 or more weeks completed gestation and which did not, at any time, breathe or show signs of life | Up to 60 months | |
Secondary | Number of babies born preterm | A baby born before 37 weeks gestation | Up to 60 months | |
Secondary | Number of neonatal deaths in England | A live born baby (born at 20+0 weeks gestational age or later, or with a birthweight of 400g or more where an accurate estimate of gestation is not available), who died before 28 completed days after birth | Up to 60 months | |
Secondary | Number of babies born small for gestational age (SGA) | Birthweight less than the 10th percentile for gestational age | Up to 60 months | |
Secondary | Number of women who had a caesarean section | Women delivering by emergency or elective caesarean section | Up to 60 months | |
Secondary | Number of women who had induction of labour | Induced delivieries | Up to 60 months | |
Secondary | Number of women who had an instrumental delivery | Women who had a forceps or ventouse delivery | Up to 60 months | |
Secondary | Number of women who had a spontaneous delivery | Spontaneous delivery without forceps or ventouse delivery | Up to 60 months | |
Secondary | Number of babies admitted to neonatal care | A baby first admitted at the given quarter to any neonatal care unit | Up to 84 months | |
Secondary | Number of babies admitted to neonatal care by gestation | A baby first admitted at the given quarter to a neonatal care unit by gestation weeks at birth | Up to 84 months | |
Secondary | Number of babies admitted to neonatal care by cause of death | A baby first admitted at the given quarter to a neonatal care unit by clinical diagnosis | Up to 84 months | |
Secondary | Number of babies who died whilst on neonatal care | A baby first admitted at any given quarter to a neonatal care unit that died at any point | Up to 84 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 |